Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Alpha Teknova, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
SC 13G/A
| Telegraph Hill Partners IV, L.P. reports a 62.9% stake in Alpha Teknova, Inc. |
| 09/27/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 08/14/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/11/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/10/2023 |
8-K
| Quarterly results|
Docs:
|
"Teknova Reports Second Quarter 2023 Financial Results Second quarter 2023 total revenue was $11.5 million, up 26% sequentially Received certification of new state-of-the-art facility for production of GMP-grade products Company revises 2023 revenue guidance to $37-40 million, continues to anticipate free cash outflows of $30 million for full year HOLLISTER, Calif., August 10, 2023 – Alpha Teknova, Inc. , a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced financial results for the second quarter ended June 30, 2023. “Today we reported strong operating results for the second quarter of 2023, increasing revenue sequentially by 26%, despite a challenging market environment..." |
|
| 07/10/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/31/2023 |
4
| Davis Ted (10% Owner) has filed a Form 4 on Alpha Teknova, Inc.|
Txns:
| Bought 1,000 shares
@ $3.26, valued at
$3.3k
Bought 1,000 shares
@ $3.17, valued at
$3.2k
|
|
| 05/31/2023 |
4
| Davis Irene (10% Owner) has filed a Form 4 on Alpha Teknova, Inc.|
Txns:
| Bought 1,000 shares
@ $3.26, valued at
$3.3k
Bought 1,000 shares
@ $3.17, valued at
$3.2k
|
|
| 05/17/2023 |
4
| Hood Lisa (Chief People Officer) has filed a Form 4 on Alpha Teknova, Inc.|
Txns:
| Sold 3,119 shares
@ $2.0362, valued at
$6.4k
|
|
| 05/16/2023 |
4
| Gunstream Stephen (President and CEO) has filed a Form 4 on Alpha Teknova, Inc.|
Txns:
| Bought 4,665 shares
@ $1.666, valued at
$7.8k
|
|
| 05/16/2023 |
4
| Gelhaus Ken (Chief Commercial Officer) has filed a Form 4 on Alpha Teknova, Inc.|
Txns:
| Bought 3,915 shares
@ $1.666, valued at
$6.5k
|
|
| 05/16/2023 |
4
| Hood Lisa (Chief People Officer) has filed a Form 4 on Alpha Teknova, Inc.|
Txns:
| Bought 3,119 shares
@ $1.666, valued at
$5.2k
|
|
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/28/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/28/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/28/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/15/2023 |
8-K
| Quarterly results|
Docs:
|
"Teknova Reports Fourth Quarter and Full Year 2022 Financial Results Full year 2022 total revenue was $41.4 million, up 12% year-over-year New, state-of-the-art manufacturing facility now operational Company provides 2023 revenue guidance of $42-46 million HOLLISTER, Calif., March 15, 2023 – Alpha Teknova, Inc. , a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced financial results for the fourth quarter and the full year ended December 31, 2022. “We achieved our operational objectives in 2022, positioning the company for significant and sustainable long-term growth,” said Stephen Gunstream, President and Chief Executive Officer of Teknova. “Despi..." |
|
| 03/01/2023 |
4
| Terrill Damon (General Counsel and CCO) has filed a Form 4 on Alpha Teknova, Inc.|
Txns:
| Granted 14,000 shares
@ $0
Granted 28,000 options to buy
@ $5.41, valued at
$151.5k
|
|
| 03/01/2023 |
4
| Lowell Matthew (CFO) has filed a Form 4 on Alpha Teknova, Inc.|
Txns:
| Granted 14,000 shares
@ $0
Granted 28,000 options to buy
@ $5.41, valued at
$151.5k
|
|
| 03/01/2023 |
4
| Hood Lisa (Chief People Officer) has filed a Form 4 on Alpha Teknova, Inc.|
Txns:
| Granted 14,000 shares
@ $0
Granted 28,000 options to buy
@ $5.41, valued at
$151.5k
|
|
| 03/01/2023 |
4
| Gunstream Stephen (President and CEO) has filed a Form 4 on Alpha Teknova, Inc.|
Txns:
| Granted 43,125 shares
@ $0
Granted 86,250 options to buy
@ $5.41, valued at
$466.6k
|
|
| 03/01/2023 |
4
| Gelhaus Ken (Chief Commercial Officer) has filed a Form 4 on Alpha Teknova, Inc.|
Txns:
| Granted 14,000 shares
@ $0
Granted 28,000 options to buy
@ $5.41, valued at
$151.5k
|
|
| 01/30/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 11/17/2022 |
4
| Terrill Damon (General Counsel and CCO) has filed a Form 4 on Alpha Teknova, Inc.|
Txns:
| Granted 30,000 options to buy
@ $5.36, valued at
$160.8k
|
|
| 11/17/2022 |
4
| Lowell Matthew (CFO) has filed a Form 4 on Alpha Teknova, Inc.|
Txns:
| Granted 33,093 options to buy
@ $5.36, valued at
$177.4k
|
|
| 11/17/2022 |
4
| Hood Lisa (Chief People Officer) has filed a Form 4 on Alpha Teknova, Inc.|
Txns:
| Bought 772 shares
@ $10.931, valued at
$8.4k
Bought 2,046 shares
@ $4.233, valued at
$8.7k
Sold 2,046 shares
@ $5.2841, valued at
$10.8k
Granted 40,498 options to buy
@ $5.36, valued at
$217.1k
|
|
| 11/17/2022 |
4
| Gunstream Stephen (President and CEO) has filed a Form 4 on Alpha Teknova, Inc.|
Txns:
| Bought 1,292 shares
@ $10.931, valued at
$14.1k
Bought 1,716 shares
@ $4.233, valued at
$7.3k
Granted 87,500 options to buy
@ $5.36, valued at
$469k
|
|
| 11/17/2022 |
4
| Gelhaus Ken (Chief Commercial Officer) has filed a Form 4 on Alpha Teknova, Inc.|
Txns:
| Bought 1,422 shares
@ $4.233, valued at
$6k
Granted 72,500 options to buy
@ $5.36, valued at
$388.6k
|
|
| 11/09/2022 |
8-K
| Quarterly results|
Docs:
|
"Teknova Reports Third Quarter 2022 Financial Results Third quarter 2022 total revenue was $10.7 million, up 14% year-over-year Company updates 2022 revenue outlook to $40-42 million Cash position of $50 million supports path to profitability HOLLISTER, Calif., November 9, 2022 – Alpha Teknova, Inc. , a leading provider of critical reagents for the discovery, research, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced financial results for the third quarter ended September 30, 2022. “Teknova delivered a solid third quarter revenue performance, driven by robust Lab Essentials growth and healthy demand across our broad customer base,” said Stephen Gunstream, President and CEO of Teknova. “Most recently, we ent..." |
|
| 10/04/2022 |
4
| Gunstream Stephen (President and CEO) has filed a Form 4 on Alpha Teknova, Inc.|
Txns:
| Exercised 40,000 shares
@ $0.8368, valued at
$33.5k
Exercised 40,000 options to buy
@ $0 |
|
| 09/02/2022 |
4
| Lowell Matthew (CFO) has filed a Form 4 on Alpha Teknova, Inc.|
Txns:
| Bought 10,000 shares
@ $4.6096, valued at
$46.1k
|
|
| 08/25/2022 |
4
| MACKOWSKI J MATTHEW (Director) has filed a Form 4 on Alpha Teknova, Inc.|
Txns:
| Bought 5,000 shares
@ $4.98, valued at
$24.9k
Bought 5,000 shares
@ $4.97, valued at
$24.9k
|
|
| 08/15/2022 |
4
| Gunstream Stephen (President and CEO) has filed a Form 4 on Alpha Teknova, Inc.|
Txns:
| Bought 18,000 shares
@ $5.1299, valued at
$92.3k
|
|
| 08/11/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
|
|
|